Transport Pharmaceuticals Device/Drug Combo For Herpes To Launch In 2007
This article was originally published in The Gray Sheet
Executive Summary
Transport Pharmaceuticals expects to file a 510(k) by early 2007 for a device/drug combination system that treats oral herpes in a single, 10-minute application
You may also be interested in...
Glaxo Licensing Deal Signals Confidence In Electrical Drug Delivery Treatment
Transport Pharmaceuticals intends to launch a 600-patient, Phase III study of its iontophoretic drug delivery device the week of March 1 to support European market go-ahead by early 2006
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.